
Angel
®
cPRP System
Operator’s Manual
ii
Before You Get Started
1. The use of operating or maintenance procedures other than those published by
Cytomedix, Inc., or the use of accessory devices not recommended by Cytomedix,
Inc. may result in poor equipment performance.
Cytomedix, Inc. will not be responsible for patient safety or equipment performance
if the procedures to operate and maintain the Angel
®
Concentrated Platelet Rich
Plasma (cPRP) System are other than those specified by Cytomedix, Inc. Persons
performing the procedures must be properly trained and qualified.
Any equipment modifications must be performed by qualified persons and be
approved by Cytomedix, Inc. in writing.
All electrical installations must comply with all applicable local electrical codes and
Cytomedix, Inc. specifications.
This equipment meets the following standards in the United States and the user
does not need to provide additional efforts regarding electromagnetic emissions
or immunity:
• EN 55011, Class A standards (for electromagnetic emissions)
• EN 61000 (for electromagnetic emissions)
• IEC 60601-1-2 (2007) (for electromagnetic immunity)
• Canadian Warning: This equipment is intended for use by healthcare
professionals only. The Angel
®
Concentrated Platelet Rich Plasma (cPRP)
System may cause radio interference or may disrupt the operation of nearby
equipment. It may be necessary to take mitigation measures, such as re-
orienting or relocating the Angel
®
Concentrated Platelet Rich Plasma (cPRP)
System or shielding the location.
2. The operator should never touch the data port on the Angel
®
cPRP System, while at
the same time making contact with the patient, as potential for electrical shock may
result.
3. Place the Angel
®
Concentrated Platelet Rich Plasma (cPRP) System on a flat, stable
surface. Never try to move the Angel
®
Concentrated Platelet Rich Plasma (cPRP)
System while the device is in operation. Failure to comply may result in damage to
the Angel
®
Concentrated Platelet Rich Plasma (cPRP) System and injury may result.
4. Do not use the Angel
®
Concentrated Platelet Rich Plasma (cPRP) System in the
presence of flammable agents because an explosion and/or fire may result.
5. A trained operator should be present at all times to operate and monitor the Angel
®
Concentrated Platelet Rich Plasma (cPRP) System during processing.
6. Do not contact any moving parts of the centrifuge or pump while the Angel
®
Concentrated Platelet Rich Plasma (cPRP) System is in operation. Injury may result.
7. To prevent risk of electrical shock, do not use alternate power plugs or adapters that
disconnect the safety ground.
8. Only Angel
®
cPRP Processing Sets are approved for patient use with the Angel
®
Concentrated Platelet Rich Plasma (cPRP) System.
9. Do not use the Angel
®
cPRP Processing Set if the sterile packaging barrier has
been broken.
Warnings